THE USE OF A TRAINING 3D-MODEL IN THE TREATMENT OF A PATIENT WITH A PATHOLOGICAL FRACTURE OF THE PROXIMAL PART OF THE FEMUR (CASE FROM PRACTICE)

Authors

  • Oleg Drobotun Kyiv City Clinical Hospital. Ukrain, Ukraine
  • Sergii Konovalenko Institute of Experimental Pathology, Oncology and Radiobiology, National Academy of Sciences of Ukraine, Kyiv, Ukraine
  • Mykola Ternovyi Institute of Experimental Pathology, Oncology and Radiobiology, National Academy of Sciences of Ukraine, Kyiv, Ukraine

DOI:

https://doi.org/10.15674/0030-59872024153-58

Keywords:

Oncology, bone metastases, pathological fracture, 3D-modeling, personalized treatment, quality of life

Abstract

Prostate cancer is the second most common cause of malignancy in men, with bone metastases being a significant source of morbidity and mortality in advanced cases. Objective. To give a clinical example of a patient with a pathological transtrochanteric fracture of the right femur with displacement
of fragments, the presence of metastasis at the fracture site, to emphasize the importance of 3D-training before surgery. Methods. A clinical example with a significant impairment of the function of the right lower extremity against the background of a significant pain syndrome is given. The diagnosis was established: pathological transtrochanteric fracture of the right femur with displacement of fragments, the presence of metastasis at the fracture site. Pre-surgical training was carried out using a 3D-model and total endoprosthetics of the right hip joint with a revision individual implant of the cement fixation
type was carried out. The patient fully recovered the function of the right lower limb and hip joint, the pain syndrome was eliminated, and sleep normalized. The use of a 3D-model for preoperative training of surgeons made it possible to rationally limit traumatization of healthy tissues during tumor removal,
prevent possible complications and optimize the time of surgical intervention and thus minimize blood loss. Conclusions. The use of a training 3D-model before surgery followed by prosthetics with a special oncological endoprosthesis provided satisfactory functional results and restoration of the patient's quality of life in the given clinical case. The use of a 3D-model is the key to careful preparation for surgical intervention, taking into account the individual anatomical features of the pathological process and adjacent tissues, which allows you to significantly optimize the terms of the operation and reduce blood loss, and also provides valuable experience for further surgical practice.

Author Biographies

Oleg Drobotun, Kyiv City Clinical Hospital. Ukrain

MD, PhD

Sergii Konovalenko, Institute of Experimental Pathology, Oncology and Radiobiology, National Academy of Sciences of Ukraine, Kyiv

MD, PhD

Mykola Ternovyi, Institute of Experimental Pathology, Oncology and Radiobiology, National Academy of Sciences of Ukraine, Kyiv

MD, Prof. in Traumatology and Orthopаedics

References

  1. Verbruggen, S. W. (2024). Role of the osteocyte in bone metastasis — The importance of networking. Journal of Bone Oncology, 44, 100526. https://doi.org/10.1016/j.jbo.2024.100526
  2. Zhou, W., Zhang, W., Yan, S., Zhang, K., Wu, H., Chen, H., Shi, M., & Zhou, T. (2024). Novel Therapeutic Targets on the Horizon: An Analysis of Clinical Trials on Therapies for Bone Metastasis in Prostate Cancer. Cancers, 16(3), 627. https://doi.org/10.3390/cancers16030627
  3. Mohseninia, N., Zamani-Siahkali, N., Harsini, S., Divband, G., Pirich, C., & Beheshti, M. (2024). Bone Metastasis in Prostate Cancer: Bone Scan Versus PET Imaging. Seminars in Nuclear Medicine, 54(1):97-118. https://doi.org/10.1053/j.semnuclmed.2023.07.004
  4. Gorodetska, I., Offermann, A., Püschel, J., Lukiyanchuk, V., Gaete, D., Kurzyukova, A., Freytag, V., Haider, M.-T., Fjeldbo, C. S., Di Gaetano, S., Schwarz, F. M., Patil, S., Borkowetz, A., Erb, H. H. H., Baniahmad, A., Mircetic, J., Lyng, H., Löck, S., Linge, A., ... Dubrovska, A. (2024). ALDH1A1 drives prostate cancer metastases and radioresistance by interplay with AR- and RAR-dependent transcription. Theranostics, 14(2), 714–737. https://doi.org/10.7150/thno.88057
  5. Boopathi, E., Birbe, R., Shoyele, S. A., Den, R. B., & Thangavel, C. (2022). Bone Health Management in the Continuum of Prostate Cancer Disease. Cancers, 14(17), 4305. https://doi.org/10.3390/cancers14174305
  6. Sun, J., Tian, T., Wang, N., Jing, X., Qiu, L., Cui, H., Liu, Z., Liu, J., Yan, L., & Li, D. (2024). Pretreatment level of serum sialic acid predicts both qualitative and quantitative bone metastases of prostate cancer. Frontiers in Endocrinology, 15. https://doi.org/10.3389/fendo.2024.1338420
  7. Zhang, Y.-F., Zhou, C., Guo, S., Wang, C., Yang, J., Yang, Z.-J., Wang, R., Zhang, X., & Zhou, F.-H. (2024). Deep learning algorithm-based multimodal MRI radiomics
  8. and pathomics data improve prediction of bone metastases in primary prostate cancer. Journal of Cancer Research and Clinical Oncology, 150(2), 78. https://doi.org/10.1007/s00432-023-05574-5
  9. Poirier, J. L., Wurtz, L. D., & Collier, C. D. (2023). Increased Number of Medical Comorbidities Associated With Increased Risk of Presenting With Pathological
  10. Femur Fracture in Metastatic Bone Disease. Iowa Orthop J., 43(1), 87–93.
  11. Gillespie, E. F., Yang, J. C., Mathis, N. J., Marine, C. B., White, C., Zhang, Z., Barker, C. A., Kotecha, R., McIntosh, A., Vaynrub, M., Bartelstein, M. K., Mitchell, A., Guttmann, D. M., Yerramilli, D., Higginson, D. S., Yamada, Y.J., Kohutek, Z. A., Powell, S. N., Tsai, J., & Yang, J. T. (2024). Prophylactic Radiation Therapy Versus Standard of Care for Patients With High-Risk Asymptomatic Bone Metastases: A Multicenter, Randomized Phase II Clinical Trial. Journal of Clinical Oncology, 42(1), 38-46. https://doi.org/10.1200/jco.23.00753
  12. Sartor, O. (2023). Radium-223 and bone metastatic disease: still more to learn. JNCI Cancer Spectrum, 7(6). https://doi.org/10.1093/jncics/pkad083
  13. Scimeca, M. (2023). Bone Metastasis Challenge: New Ideas and Future. International Journal of Molecular Sciences, 24(7), 6161. https://doi.org/10.3390/ijms24076161
  14. Bocchi, M. B., Meschini, C., Pietramala, S., Perna, A., Oliva, M. S., Matrangolo, M. R., Ziranu, A., Maccauro, G., & Vitiello, R. (2023). Electrochemotherapy in the
  15. Treatment of Bone Metastases: A Systematic Review. Journal of Clinical Medicine, 12(19), 6150. https://doi.org/10.3390/jcm12196150
  16. Christ, A. B., Piple, A. S., Gettleman, B. S., Duong, A., Chen, M., Wang, J. C., Heckmann, N. D., & Menendez, L. (2023). Prevalence of primary malignant tumours, rates of pathological fracture, and mortality in the setting of metastatic bone disease. Bone & Joint Open, 4(6), 424–431. https://doi.org/10.1302/2633-1462.46.bjo-2023-0042.r1
  17. Shen, F., Huang, J., Yang, K., & Sun, C. (2023). A Comprehensive Review of Interventional Clinical Trials in Patients with Bone Metastases. OncoTargets and Therapy, Volume, 16, 485–495. https://doi.org/10.2147/ott.s415399
  18. Gonzalez, M. R., Bryce-Alberti, M., & Pretell-Mazzini, J. (2022). Management of Long Bones Metastatic Disease: Concepts That We All Know but Not Always Remember. Orthopedic Research and Reviews, Volume 14, 393–406. https://doi.org/10.2147/orr.s379603
  19. Lan, H., Wu, B., Jin, K., & Chen, Y. (2024). Beyond boundaries: unraveling innovative approaches to combat bone-metastatic cancers. Frontiers in Endocrinology, 14. https://doi.org/10.3389/fendo.2023.1260491
  20. Park, J. H., Won, J., Kim, H. S., Kim, Y., Kim, S., & Han, I. (2024). Comparison of survival prediction models for bone metastases of the extremities following surgery. Bone Joint J., 106-B(2), 203–211.
  21. Hoeben, A., Joosten, E. A. J., & van den Beuken-van Everdingen, M. H. J. (2021). Personalized Medicine: Recent Progress in Cancer Therapy. Cancers, 13(2), 242. https://doi.org/10.3390/cancers13020242
  22. Konovalenko, V. (2015). Tumors and tumor-like diseases of bones and joints (clinic, diagnosis, treatment) [manual]. Kyiv: Lazurit-Polygraph.
  23. Martelli, N., Serrano, C., van den Brink, H., Pineau, J., Prognon, P., Borget, I., & El Batti, S. (2016). Advantages and disadvantages of 3-dimensional printing in surgery: A systematic review. Surgery, 159(6), 1485–1500. https://doi.org/10.1016/j.surg.2015.12.017
  24. Requena-Pérez, M. V., Andrés-Cano, P., Galán-Romero, L., & Suffo, M. (2024). Comparative study of biomodels manufactured using 3D printing techniques for surgical planning and medical training. Expert Review of Medical Devices, 1–10. https://doi.org/10.1080/17434440.2024.2306884

Downloads

How to Cite

Drobotun, O. ., Konovalenko, S. ., & Ternovyi, M. . (2024). THE USE OF A TRAINING 3D-MODEL IN THE TREATMENT OF A PATIENT WITH A PATHOLOGICAL FRACTURE OF THE PROXIMAL PART OF THE FEMUR (CASE FROM PRACTICE). ORTHOPAEDICS TRAUMATOLOGY and PROSTHETICS, (1), 53–58. https://doi.org/10.15674/0030-59872024153-58

Issue

No. 1 (2024)

Section

SHORT REPORTS AND NEWS FROM PRACTICE

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

The authors retain the right of authorship of their manuscript and pass the journal the right of the first publication of this article, which automatically become available from the date of publication under the terms of Creative Commons Attribution License, which allows others to freely distribute the published manuscript with mandatory linking to authors of the original research and the first publication of this one in this journal.

Authors have the right to enter into a separate supplemental agreement on the additional non-exclusive distribution of manuscript in the form in which it was published by the journal (i.e. to put work in electronic storage of an institution or publish as a part of the book) while maintaining the reference to the first publication of the manuscript in this journal.

The editorial policy of the journal allows authors and encourages manuscript accommodation online (i.e. in storage of an institution or on the personal websites) as before submission of the manuscript to the editorial office, and during its editorial processing because it contributes to productive scientific discussion and positively affects the efficiency and dynamics of the published manuscript citation (see The Effect of Open Access).